60 mg vial tirzepatide - 60mg I have a vial that

Most research suggests a daily dose of 500-2,000 mg

POTS has often been partitioned into subsets, e.g., neuropathic, hyperadrenergic, low flow, high flow, and these can overlap

Feeling cold on tirzepatide and cold sensitivity with semaglutide (which shares the same mechanism as liraglutide) are well-documented experiences

The class II HLA molecules that are associated with increased risk of T1D have been shown to bind peptides derived from the currently identified autoantigens described above and present these peptides to CD4 + T cells which then activate CD8 + cytotoxic T cells resulting in killing of islet cells